Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Droice Labs is a private healthcare AI and data infrastructure company focused on converting messy real-world patient data into analysis-ready datasets for biopharma and healthcare customers. Its core commercial platform, Hawk, is a HIPAA/GDPR-compliant AI middleware system designed to ingest and harmonize EHR, claims, lab, and other real-world data sources for clinical trials and evidence generation. The company also promotes SuperLineage, a regulatory-grade data lineage and traceability framework, and Flamingo, an LLM-based medical text understanding capability for multilingual clinical free text. Rather than developing therapeutics, Droice supports drug development, regulatory evidence generation, and reimbursement decision-making through data processing, traceability, and real-world evidence workflows. The company appears to be therapeutic-area agnostic and works across chronic and rare diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Droice Labs.